RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+33.41%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.57B
AUM Growth
+$2.57B
(+21%)
Cap. Flow
-$34.8M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
31.92%
Holding
139
New
6
Increased
46
Reduced
13
Closed
9
Top Buys
| 1 |
CVET
Covetrus, Inc. Common Stock
CVET
|
$20.7M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$20M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$16.9M |
| 4 |
Cigna
CI
|
$14.5M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$10.8M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$44.7M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
$33.8M |
| 3 |
Molina Healthcare
MOH
|
$19.1M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$18.7M |
| 5 |
Biogen
BIIB
|
$15M |
Sector Composition
| 1 | Healthcare | 86.14% |
| 2 | Consumer Staples | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $146M | 5.63% | 591,000 -12,100 | -2% | -$2.99M |
|
|
GWPH
2
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $118M | 4.55% | 700,000 +100,500 | +17% | +$16.9M |
|
|
AMRN
3
Amarin Corp
AMRN
$311M
| $93.9M | 3.62% | 4,525,000 +49,000 | +1% | +$1.02M |
|
4
Intuitive Surgical
ISRG
$170B
| $87M | 3.35% | 152,500 +500 | +0.3% | +$285K |
|
|
WCG
5
DELISTED
Wellcare Health Plans, Inc.
WCG
| $86.3M | 3.33% | 320,000 -69,500 | -18% | -$18.7M |
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $74.4M | 2.87% | 844,500 +55,900 | +7% | +$4.92M |
|
|
ONCE
7
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $61.2M | 2.36% | 537,500 | – | – |
|
8
HCA Healthcare
HCA
$94.5B
| $59.3M | 2.29% | 455,000 | – | – |
|
9
Pacira BioSciences
PCRX
$1.2B
| $47.6M | 1.83% | 1,250,000 | – | – |
|
10
Encompass Health
EHC
$12.3B
| $46.7M | 1.8% | 800,000 +75,000 | +10% | +$4.38M |
|
|
11
Ultragenyx Pharmaceutical
RARE
$2.89B
| $40.2M | 1.55% | 580,000 +155,000 | +36% | +$10.8M |
|
12
Sarepta Therapeutics
SRPT
$1.78B
| $39.9M | 1.54% | 334,500 +7,500 | +2% | +$894K |
|
13
Teleflex
TFX
$5.59B
| $39.3M | 1.51% | 130,000 | – | – |
|
14
iRhythm Technologies
IRTC
$5.46B
| $37.5M | 1.44% | 499,615 +17,615 | +4% | +$1.32M |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $37.3M | 1.44% | 203,000 | – | – |
|
16
Boston Scientific
BSX
$156B
| $37.2M | 1.44% | 970,000 +55,000 | +6% | +$2.11M |
|
17
Stryker
SYK
$150B
| $35.4M | 1.36% | 179,000 | – | – |
|
18
Edwards Lifesciences
EW
$47.8B
| $35.1M | 1.35% | 183,500 | – | – |
|
19
Exact Sciences
EXAS
$8.98B
| $34.4M | 1.33% | 397,000 +12,000 | +3% | +$1.04M |
|
20
Penumbra
PEN
$10.6B
| $33.1M | 1.28% | 225,000 | – | – |
|
|
ALXN
21
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $32.8M | 1.26% | 242,500 | – | – |
|
22
Madrigal Pharmaceuticals
MDGL
$9.76B
| $32M | 1.23% | 255,250 +14,250 | +6% | +$1.78M |
|
|
PTLA
23
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $30.4M | 1.17% | 875,000 +575,000 | +192% | +$20M |
|
24
Align Technology
ALGN
$10.3B
| $29.9M | 1.15% | 105,000 | – | – |
|
|
25
Molina Healthcare
MOH
$9.8B
| $29.5M | 1.14% | 207,500 -134,500 | -39% | -$19.1M |
|